856847-94-4 Usage
Description
6-Ethyl-pyridazin-3-ylamine, also known as 6-ethyl-3-aminopyridazine, is a chemical compound with the formula C7H10N4. It is a yellow to orange solid that is used as a building block in the synthesis of pharmaceutical compounds. This chemical has demonstrated inhibitory properties against enzymes and has been studied for potential applications in the treatment of various diseases. Its structure contains a pyridazine ring with an amino group and an ethyl substituent, making it a versatile intermediate in organic synthesis. As a result, 6-Ethyl-pyridazin-3-ylamine is a valuable chemical in pharmaceutical research and development.
Uses
Used in Pharmaceutical Industry:
6-Ethyl-pyridazin-3-ylamine is used as a building block for the synthesis of pharmaceutical compounds due to its versatile intermediate properties in organic synthesis.
Used in Enzyme Inhibition:
6-Ethyl-pyridazin-3-ylamine is used as an inhibitor of enzymes for potential applications in the treatment of various diseases, as it has demonstrated inhibitory properties against enzymes.
Check Digit Verification of cas no
The CAS Registry Mumber 856847-94-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,8,4 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 856847-94:
(8*8)+(7*5)+(6*6)+(5*8)+(4*4)+(3*7)+(2*9)+(1*4)=234
234 % 10 = 4
So 856847-94-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H7ClN2/c1-2-5-3-4-6(7)9-8-5/h3-4H,2H2,1H3
856847-94-4Relevant articles and documents
RAD51 INHIBITORS
-
Page/Page column 231-232, (2020/09/27)
This application is directed to inhibitors of RAD51 represented by the following structural formula, (I), and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
1-(6-MEMBERED AZO-HETEROCYCLIC)-2,5-DIHYDRO-1H-PYRROL-2-ONE DERIVATIVES AS ANTI-HEPATITIS C VIRUS, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE
-
Page/Page column 45, (2012/07/27)
The present invention concerns 1-(6-memberedazo-heterocyclic)-2,5-dihydro–1H–pyrrol–2-one compoundsof the following formula (I) or a salt, solvate, tautomer, isotope, enantiomer, diastereoisomer or racemic mixture thereof: the pharmaceutical composition thereof and their therapeutic use as inhibitors of Hepatitis C virus.
